To determine the involvement of RRM2 and RRM2B in HB cell drug response, we treated tdT, RRM2OE and RRM2BOE HepG2 cells with six common liver cancer drugs and the two RRM2 inhibitors triapine and MK1775. The gene discussed is DNTT; the disease is liver cancer.